AU3078000A - Heterocyclic compounds and antitumor agents containing the same as the active ingredient - Google Patents
Heterocyclic compounds and antitumor agents containing the same as the active ingredientInfo
- Publication number
- AU3078000A AU3078000A AU30780/00A AU3078000A AU3078000A AU 3078000 A AU3078000 A AU 3078000A AU 30780/00 A AU30780/00 A AU 30780/00A AU 3078000 A AU3078000 A AU 3078000A AU 3078000 A AU3078000 A AU 3078000A
- Authority
- AU
- Australia
- Prior art keywords
- same
- active ingredient
- heterocyclic compounds
- agents containing
- antitumor agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11/16216 | 1999-01-25 | ||
JP1621699 | 1999-01-25 | ||
PCT/JP2000/000348 WO2000043385A1 (en) | 1999-01-25 | 2000-01-25 | Heterocyclic compounds and antitumor agents containing the same as the active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3078000A true AU3078000A (en) | 2000-08-07 |
Family
ID=11910342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU30780/00A Abandoned AU3078000A (en) | 1999-01-25 | 2000-01-25 | Heterocyclic compounds and antitumor agents containing the same as the active ingredient |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP4709388B2 (en) |
AU (1) | AU3078000A (en) |
WO (1) | WO2000043385A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60217322T2 (en) * | 2001-04-27 | 2007-10-04 | Zenyaku Kogyo K.K. | Heterocyclic compound and antitumor agent containing it as an active ingredient |
JP4493503B2 (en) * | 2002-10-25 | 2010-06-30 | 全薬工業株式会社 | Heterocyclic compounds and antitumor agents containing the same as active ingredients |
CA2599879C (en) * | 2005-03-11 | 2013-07-02 | Zenyaku Kogyo Kabushikikaisha | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
WO2008032027A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | Pyrimidine derivatives |
WO2008032077A1 (en) * | 2006-09-14 | 2008-03-20 | Astrazeneca Ab | Pyrimidine derivatives |
PT2409975E (en) | 2007-11-22 | 2015-07-27 | Zenyaku Kogyo Kk | Solid dispersions comprising an amorphous body composed of a heterocyclic anti-tumor compound |
GB2465405A (en) * | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
KR20110120286A (en) | 2009-02-12 | 2011-11-03 | 아스텔라스세이야쿠 가부시키가이샤 | Hetero ring derivative |
CN105859689A (en) * | 2009-12-28 | 2016-08-17 | 财团法人生物技术开发中心 | Novel pyrimidine compounds as mTOR and P13K inhibitors |
US9315491B2 (en) | 2009-12-28 | 2016-04-19 | Development Center For Biotechnology | Pyrimidine compounds as mTOR and PI3K inhibitors |
JP5765342B2 (en) | 2010-08-10 | 2015-08-19 | アステラス製薬株式会社 | Heterocyclic compounds |
TW201815787A (en) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | Phosphatidylinositol 3-kinase inhibitors |
TW201813963A (en) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | Phosphatidylinositol 3-kinase inhibitors |
TW201825465A (en) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | Phosphatidylinositol 3-kinase inhibitors |
CN114149418B (en) * | 2021-11-15 | 2024-03-01 | 天津医科大学 | High morpholine compound, preparation method, pharmaceutical composition and application |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04276376A (en) * | 1991-03-04 | 1992-10-01 | Fujitsu Ltd | Fifo memory provided with pointer en function |
DE69408750T2 (en) * | 1993-08-26 | 1998-07-23 | Ono Pharmaceutical Co | 4-aminopyrimidine derivatives |
TW312694B (en) * | 1994-09-26 | 1997-08-11 | Daiichi Seiyaku Co | |
EP1020462B1 (en) * | 1997-07-24 | 2004-02-11 | Zenyaku Kogyo Kabushiki Kaisha | Heterocyclic compounds and antitumor agent containing the same as active ingredient |
-
2000
- 2000-01-25 JP JP2000594801A patent/JP4709388B2/en not_active Expired - Lifetime
- 2000-01-25 WO PCT/JP2000/000348 patent/WO2000043385A1/en active Application Filing
- 2000-01-25 AU AU30780/00A patent/AU3078000A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP4709388B2 (en) | 2011-06-22 |
WO2000043385A1 (en) | 2000-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002253619A1 (en) | Heterocyclic compound and antitumor agent containing the same active ingredients | |
AU2300699A (en) | Amidino derivatives and drugs containing the same as the active ingredient | |
AU3076700A (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
IL148517A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
HK1035194A1 (en) | Novel pyridazine derivatives and drugs containing the same as the active ingredient | |
AU2002226674A1 (en) | Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient | |
IL150077A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
AU7962200A (en) | Novel indole derivatives and drugs containing the same as the active ingredient | |
HK1086830A1 (en) | Heterocyclic compounds and antitumor drugs containing the same as the active ingredient | |
AU4137400A (en) | Heterocyclic derivatives useful as anticancer agents | |
IL144977A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
EP1114816A4 (en) | $g(v)-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | |
AU1690399A (en) | Neovascularization inhibitor containing dienogest as the active ingredient | |
EP1067130A4 (en) | Triazolo derivatives and chemokine inhibitors containing the same as the active ingredient | |
AU6876800A (en) | Pyrimidine derivatives and herbicides containing the same | |
AU3053199A (en) | Fused thiophene derivatives and drugs containing the same as the active ingredient | |
IL149883A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
AU3078000A (en) | Heterocyclic compounds and antitumor agents containing the same as the active ingredient | |
AU6309698A (en) | Drugs containing aminopyridine derivatives as the active ingredient | |
AU2001288114A1 (en) | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | |
AU2001286242A1 (en) | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | |
AU1650401A (en) | Oxadiazole derivatives and drugs containing these derivatives as the active ingredient | |
AU2001277738A1 (en) | Piperidine derivatives and drugs containing these derivatives as the active ingredient | |
AU4431400A (en) | Anticancer agents containing ep1 antagonists as the active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |